MONTREAL, March 27, 2020 (GLOBE NEWSWIRE) -- People infected with COVID-19 diagnosed in the last 24 hours can call 1-877-536-6837 to participate in clinical research aimed to stop the progression of the disease.

The clinical study is a public service offered to anyone 40 years and older who has been diagnosed with COVID-19 and who is not hospitalized.

The study, called COLCORONA, aims to determine whether short-term treatment based on colchicine would reduce the risk of pulmonary complications and death related to COVID-19. More specifically COLCORONA studies the phenomenon of major inflammatory storm present in adults suffering from severe complications related to COVID-19.

Information: https://www.colcorona.org

About the Montreal Heart Institute
Founded in 1954, the Montreal Heart Institute constantly strives for the highest standards of excellence in the cardiovascular field through its leadership in clinical and basic research, ultra-specialized care, professional training and prevention. It is home to the largest cardiology research center in Canada, the largest cardiovascular prevention center in the country, and the largest cardiovascular genetics center in the country. The Institute is affiliated with the University of Montreal and has more than 2,000 employees, including 245 physicians and more than 85 researchers. www.icm-mhi.org

Media relations:
Camille Turbide
Camille.turbide@gmail.com
514 755-5354